CDH1 and breast cancer: Moderate/high LIV-1 expression has been found in about 90% of both HR-positive BC and TNBC [45] and it is associated with nodal and distant metastatic progression, consistently with its role in the epithelial-mesenchymal transition, through E-cadherin downregulation [46].